362 related articles for article (PubMed ID: 34017167)
1. Multiple Sclerosis Biomarker Discoveries by Proteomics and Metabolomics Approaches.
Jafari A; Babajani A; Rezaei-Tavirani M
Biomark Insights; 2021; 16():11772719211013352. PubMed ID: 34017167
[TBL] [Abstract][Full Text] [Related]
2. Proteomics in Multiple Sclerosis: The Perspective of the Clinician.
Sandi D; Kokas Z; Biernacki T; Bencsik K; Klivényi P; Vécsei L
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563559
[TBL] [Abstract][Full Text] [Related]
3. Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine.
Del Boccio P; Rossi C; di Ioia M; Cicalini I; Sacchetta P; Pieragostino D
Proteomics Clin Appl; 2016 Apr; 10(4):470-84. PubMed ID: 27061322
[TBL] [Abstract][Full Text] [Related]
4. Proteomic Approaches to Decipher Mechanisms Underlying Pathogenesis in Multiple Sclerosis Patients.
Singh V; Tripathi A; Dutta R
Proteomics; 2019 Aug; 19(16):e1800335. PubMed ID: 31119864
[TBL] [Abstract][Full Text] [Related]
5. Genomic, proteomic, and systems biology approaches in biomarker discovery for multiple sclerosis.
Chase Huizar C; Raphael I; Forsthuber TG
Cell Immunol; 2020 Dec; 358():104219. PubMed ID: 33039896
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics in multiple sclerosis.
Bhargava P; Calabresi PA
Mult Scler; 2016 Apr; 22(4):451-60. PubMed ID: 26754801
[TBL] [Abstract][Full Text] [Related]
7. Current and Future Biomarkers in Multiple Sclerosis.
Yang J; Hamade M; Wu Q; Wang Q; Axtell R; Giri S; Mao-Draayer Y
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682558
[TBL] [Abstract][Full Text] [Related]
8. Extracellular Vesicles as Pro- and Anti-inflammatory Mediators, Biomarkers and Potential Therapeutic Agents in Multiple Sclerosis.
Manu MS; Hohjoh H; Yamamura T
Aging Dis; 2021 Sep; 12(6):1451-1461. PubMed ID: 34527421
[TBL] [Abstract][Full Text] [Related]
9. Disease biomarkers in multiple sclerosis: potential for use in therapeutic decision making.
Harris VK; Sadiq SA
Mol Diagn Ther; 2009; 13(4):225-44. PubMed ID: 19712003
[TBL] [Abstract][Full Text] [Related]
10. Integrating multi-omics biomarkers and postprandial metabolism to develop personalized treatment for anorexia nervosa.
Shih PB
Prostaglandins Other Lipid Mediat; 2017 Sep; 132():69-76. PubMed ID: 28232135
[TBL] [Abstract][Full Text] [Related]
11. Data integration and systems biology approaches for biomarker discovery: challenges and opportunities for multiple sclerosis.
Villoslada P; Baranzini S
J Neuroimmunol; 2012 Jul; 248(1-2):58-65. PubMed ID: 22281286
[TBL] [Abstract][Full Text] [Related]
12. Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke.
Montaner J; Ramiro L; Simats A; Tiedt S; Makris K; Jickling GC; Debette S; Sanchez JC; Bustamante A
Nat Rev Neurol; 2020 May; 16(5):247-264. PubMed ID: 32322099
[TBL] [Abstract][Full Text] [Related]
13. Serum proteomics in multiple sclerosis disease progression.
Tremlett H; Dai DL; Hollander Z; Kapanen A; Aziz T; Wilson-McManus JE; Tebbutt SJ; Borchers CH; Oger J; Cohen Freue GV
J Proteomics; 2015 Apr; 118():2-11. PubMed ID: 25753122
[TBL] [Abstract][Full Text] [Related]
14. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
[TBL] [Abstract][Full Text] [Related]
15. Renal injury in neonates: use of "omics" for developing precision medicine in neonatology.
Joshi MS; Montgomery KA; Giannone PJ; Bauer JA; Hanna MH
Pediatr Res; 2017 Jan; 81(1-2):271-276. PubMed ID: 27723726
[TBL] [Abstract][Full Text] [Related]
16. Neuroproteomics and microRNAs studies in multiple sclerosis: transforming research and clinical knowledge in biomarker research.
Fawaz CN; Makki IS; Kazan JM; Gebara NY; Andary FS; Itani MM; El-Sayyed M; Zeidan A; Quartarone A; Darwish H; Mondello S
Expert Rev Proteomics; 2015; 12(6):637-50. PubMed ID: 26479122
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers in Multiple Sclerosis.
Paul A; Comabella M; Gandhi R
Cold Spring Harb Perspect Med; 2019 Mar; 9(3):. PubMed ID: 29500303
[TBL] [Abstract][Full Text] [Related]
18. [Omics biomarkers and early diagnostics].
Moshkovskii SA
Biomed Khim; 2017 Oct; 63(5):369-372. PubMed ID: 29080866
[TBL] [Abstract][Full Text] [Related]
19. Genomics, proteomics, metabolomics: what is in a word for multiple sclerosis?
Ibrahim SM; Gold R
Curr Opin Neurol; 2005 Jun; 18(3):231-5. PubMed ID: 15891405
[TBL] [Abstract][Full Text] [Related]
20. Exploring Computational Data Amplification and Imputation for the Discovery of Type 1 Diabetes (T1D) Biomarkers from Limited Human Datasets.
Alcazar O; Ogihara M; Ren G; Buchwald P; Abdulreda MH
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
